Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC16A2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | SLC16A2 Gene (MCT8) |
| Summary | Thyroid hormone transporter essential for brain development; mutations cause Allan-Herndon-Dudley syndrome |
| Key Genes/Proteins | TH, MCT8 |
| Related Diseases | Mct8 Deficiency, Cancer, Ms, Als |
| Related Pathways | Astrocytic Lactate Shuttle Enhancement for Grid Ce |
Knowledge base pages for this entity
graph TD
SLC16A2["SLC16A2"]
SLC16A2 -->|"regulates"| Astrocytic_Lactate_Shuttle_Enh["Astrocytic Lactate Shuttle Enhancement for Grid Ce"]
SLC16A2 -->|"target for"| Cancer["Cancer"]
SLC16A2 -->|"target for"| Ms["Ms"]
SLC16A2 -->|"regulates"| Tau_Propagation["Tau Propagation"]
SLC16A2 -->|"target for"| GSS["GSS"]
SLC16A2 -->|"target for"| JUN["JUN"]
SLC16A2 -->|"target for"| MICRORNAS["MICRORNAS"]
h_5ff6c5ca["h-5ff6c5ca"] -->|"targets"| SLC16A2
JUN -->|"target for"| SLC16A2
ACSL5["ACSL5"] -->|"target for"| SLC16A2
GSS -->|"activates"| SLC16A2
MICRORNAS -->|"activates"| SLC16A2
SLC16A1["SLC16A1"] -->|"transports"| SLC16A2
CYP2E1["CYP2E1"] -->|"activates"| SLC16A2| Target | Relation | Type | Str |
|---|---|---|---|
| Mct8 Deficiency | causes | disease | 1.00 |
| THYROID HORMONE METABOLISM | involved_in | entity | 0.90 |
| Astrocytic Lactate Shuttle Enhancement for Grid Ce | regulates | mechanism | 0.70 |
| TH | transported_by | gene | 0.70 |
| Cancer | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Cancer | transports | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| ALS | transports | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Als | transports | disease | 0.65 |
| Tau Propagation | regulates | biological_process | 0.60 |
| SLC16A1 | associated_with | gene | 0.60 |
| GSS | therapeutic_target | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| JUN | transports | gene | 0.60 |
| neurodegeneration | implicated_in | disease | 0.60 |
| Allan-Herndon-Dudley syndrome | causes | disease | 0.60 |
| cerebral palsy | associated_with | disease | 0.60 |
| neurodevelopmental impairment | contributes_to | disease | 0.60 |
| brain | expressed_in | brain_region | 0.60 |
| X chromosome | associated_with | pathway | 0.60 |
| cerebral hypothyroidism | contributes_to | disease | 0.60 |
| SLC16 family | involved_in | pathway | 0.60 |
| intellectual disability | contributes_to | disease | 0.60 |
| thyroid function | regulates | pathway | 0.60 |
| SLC16A1 | transports | gene | 0.60 |
| GNAO1 | associated_with | gene | 0.60 |
| ATL1 | associated_with | gene | 0.60 |
| Rb | therapeutic_target | protein | 0.60 |
| Rb | transports | protein | 0.60 |
| SATB2 | associated_with | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| Rb | causes | protein | 0.60 |
| TH | associated_with | gene | 0.60 |
| SPAST | associated_with | gene | 0.60 |
| TH | translocates_to | gene | 0.60 |
| SLCO1C1 | activates | gene | 0.60 |
| TH | disrupts | gene | 0.60 |
| neurodegeneration | transported_by | disease | 0.60 |
| SLCO1C1 | interacts_with | gene | 0.60 |
| TH | interacts_with | gene | 0.60 |
| neurodegeneration | interacts_with | disease | 0.60 |
| MICRORNAS | therapeutic_target | gene | 0.60 |
| CANCER | transports | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Mct8 Deficiency | biomarker_for | disease | 1.00 |
| h-5ff6c5ca | targets_gene | hypothesis | 0.90 |
| h-5ff6c5ca | targets | hypothesis | 0.80 |
| MCT8 | translocates_to | gene | 0.70 |
| JUN | therapeutic_target | gene | 0.60 |
| SLC16A1 | associated_with | gene | 0.60 |
| GSS | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| SLC16A1 | transports | gene | 0.60 |
| JUN | transports | gene | 0.60 |
| SLC16 FAMILY | transports | gene | 0.60 |
| GSS | therapeutic_target | gene | 0.60 |
| SPAST | associated_with | gene | 0.60 |
| COL4A1 | associated_with | gene | 0.60 |
| SATB2 | associated_with | gene | 0.60 |
| ATL1 | associated_with | gene | 0.60 |
| PDHX | associated_with | gene | 0.60 |
| GNAO1 | associated_with | gene | 0.60 |
| POLR2A | associated_with | gene | 0.60 |
| ACSL5 | therapeutic_target | gene | 0.60 |
| MICRORNAS | activates | gene | 0.60 |
| CYP2E1 | activates | gene | 0.60 |
| ACSL5 | associated_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| SLC16A3 | transports | gene | 0.60 |
| SLC16A10 | transports | gene | 0.60 |
| AND | transports | gene | 0.60 |
| MIR-375 | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| SLC16A10 | associated_with | gene | 0.60 |
| MICRORNAS | therapeutic_target | gene | 0.60 |
| MIR-375 | therapeutic_target | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| SLC16A3 | therapeutic_target | gene | 0.60 |
| CYP2E1 | therapeutic_target | gene | 0.60 |
| MCT8 | transports | gene | 0.60 |
| MCT8 | causes | gene | 0.60 |
| SLC16A10 | translocates_to | gene | 0.60 |
| MCT8 | associated_with | gene | 0.60 |
| MCT8 | activates | gene | 0.60 |
| MCT8 | interacts_with | gene | 0.60 |
| C1Q | activates | gene | 0.55 |
| phagocytosis | activates | process | 0.55 |
| MCU | debate_co_mention | gene | 0.45 |
| PPARGC1A | debate_co_mention | gene | 0.45 |
| RELN | debate_co_mention | gene | 0.45 |
| oxidative stress | debate_co_mention | process | 0.45 |
| PPARGC1A | co_discussed | gene | 0.40 |
| RELN | co_discussed | gene | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener | 0.412 | neurodegeneration | Selective vulnerability of entorhinal co |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.484
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| miR-375 protects against acetaminophen-induced acute liver failure by orchestrat [PMID:40598772] | Wang Y, Liu J, Zhu S, Hu S, Chen X, Mand | Mol Ther | 2025 | 1 |
| Defective thyroid hormone transport to the brain leads to astroglial alterations [PMID:39097035] | Guillén-Yunta M, García-Aldea Á, Valcárc | Neurobiol Dis | 2024 | 1 |
| The SLC16 gene family - structure, role and regulation in health and disease. [PMID:23506875] | Halestrap AP | Mol Aspects Med | 2013 | 1 |
| Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] | ["Ranjitha V", "Kumar A", "Kaalappa P"] | Pharmaceutical research | 2025 | 0 |
| Tiratricol: First Approval. [PMID:40549098] | ["Lamb Y"] | Drugs | 2025 | 0 |
| Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1. [PMID:40680733] | Ge Y, Dou T, Nguyen TU, Yadav GP, Wensel | Cell | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| The interactions between monocarboxylate transporter genes MCT1, MCT2, and MCT4 [PMID:39934699] | Maculewicz E, Mastalerz A, Garbacz A, Mr | BMC genomics | 2025 | 0 |
| Adrenergic regulation of astroglial aerobic glycolysis and lipid metabolism: Tow [PMID:37094775] | ["Zorec R", "Vardjan N"] | Neurobiology of disease | 2023 | 0 |
| Tsh Induces Agrp1 Neuron Proliferation in Oatp1c1-Deficient Zebrafish. [PMID:36150888] | Wasserman-Bartov T, Admati I, Lebenthal- | The Journal of neuroscience : | 2022 | 0 |
| The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer. [PMID:34097251] | Sohrabi E, Moslemi M, Rezaie E, Nafissi | Genes & genomics | 2021 | 0 |
| Thyroid Hormone Transporters. [PMID:31754699] | ["Groeneweg S", "van Geest F", "Peeters | Endocrine reviews | 2020 | 0 |
| Neural Alterations and Hyperactivity of the Hypothalamic-Pituitary-Thyroid Axis [PMID:31797746] | ["Admati I", "Wasserman-Bartov T", "Tovi | Thyroid : official journal of | 2020 | 0 |
| Disease characteristics of MCT8 deficiency: an international, retrospective, mul [PMID:32559475] | Groeneweg S, van Geest FS, Abacı A, Alca | The lancet. Diabetes & endocri | 2020 | 0 |
| Nonbiological maternal risk factor for low birth weight on Latin America: a syst [PMID:23386023] | ["da Silva T"] | Einstein (Sao Paulo, Brazil) | 2012 | 0 |
| Thyroid hormone transporters in the brain. [PMID:20879691] | Braun D, Wirth EK, Schweizer U | Reviews in the neurosciences | 2010 | 0 |
| Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome [PMID:16849530] | ["Eckerdt F", "Strebhardt K"] | Cancer research | 2006 | 0 |